Literature DB >> 18322460

Isolation of an active step I spliceosome and composition of its RNP core.

Sergey Bessonov1, Maria Anokhina, Cindy L Will, Henning Urlaub, Reinhard Lührmann.   

Abstract

Formation of catalytically active RNA structures within the spliceosome requires the assistance of proteins. However, little is known about the number and nature of proteins needed to establish and maintain the spliceosome's active site. Here we affinity-purified human spliceosomal C complexes and show that they catalyse exon ligation in the absence of added factors. Comparisons of the composition of the precatalytic versus the catalytic spliceosome revealed a marked exchange of proteins during the transition from the B to the C complex, with apparent stabilization of Prp19-CDC5 complex proteins and destabilization of SF3a/b proteins. Disruption of purified C complexes led to the isolation of a salt-stable ribonucleoprotein (RNP) core that contained both splicing intermediates and U2, U5 and U6 small nuclear RNA plus predominantly U5 and human Prp19-CDC5 proteins and Prp19-related factors. Our data provide insights into the spliceosome's catalytic RNP domain and indicate a central role for the aforementioned proteins in sustaining its catalytically active structure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322460     DOI: 10.1038/nature06842

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  204 in total

1.  Fission yeast Cactin restricts telomere transcription and elongation by controlling Rap1 levels.

Authors:  Luca E Lorenzi; Amadou Bah; Harry Wischnewski; Vadim Shchepachev; Charlotte Soneson; Marco Santagostino; Claus M Azzalin
Journal:  EMBO J       Date:  2014-11-14       Impact factor: 11.598

2.  CEF1/CDC5 alleles modulate transitions between catalytic conformations of the spliceosome.

Authors:  Charles C Query; Maria M Konarska
Journal:  RNA       Date:  2012-03-08       Impact factor: 4.942

3.  The RNA polymerase C-terminal domain: a new role in spliceosome assembly.

Authors:  Charles J David; James L Manley
Journal:  Transcription       Date:  2011 Sep-Oct

4.  Antisense-targeted immuno-EM localization of the pre-mRNA path in the spliceosomal C complex.

Authors:  Elmar Wolf; Berthold Kastner; Reinhard Lührmann
Journal:  RNA       Date:  2012-05-24       Impact factor: 4.942

5.  Contribution of DEAH-box protein DHX16 in human pre-mRNA splicing.

Authors:  Marieta Gencheva; Mitsuo Kato; Alain N S Newo; Ren-Jang Lin
Journal:  Biochem J       Date:  2010-07-01       Impact factor: 3.857

6.  Analysis of spliceosomal proteins in Trypanosomatids reveals novel functions in mRNA processing.

Authors:  Itai Dov Tkacz; Sachin Kumar Gupta; Vadim Volkov; Mali Romano; Tomer Haham; Pawel Tulinski; Ilana Lebenthal; Shulamit Michaeli
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

Review 7.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

8.  Functional organization of the Sm core in the crystal structure of human U1 snRNP.

Authors:  Gert Weber; Simon Trowitzsch; Berthold Kastner; Reinhard Lührmann; Markus C Wahl
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

9.  Structure of the 30 kDa HIV-1 RNA Dimerization Signal by a Hybrid Cryo-EM, NMR, and Molecular Dynamics Approach.

Authors:  Kaiming Zhang; Sarah C Keane; Zhaoming Su; Rossitza N Irobalieva; Muyuan Chen; Verna Van; Carly A Sciandra; Jan Marchant; Xiao Heng; Michael F Schmid; David A Case; Steven J Ludtke; Michael F Summers; Wah Chiu
Journal:  Structure       Date:  2018-02-02       Impact factor: 5.006

10.  A large intrinsically disordered region in SKIP and its disorder-order transition induced by PPIL1 binding revealed by NMR.

Authors:  Xingsheng Wang; Shaojie Zhang; Jiahai Zhang; Xiaojuan Huang; Chao Xu; Weiwei Wang; Zhijun Liu; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.